Medidata, part of Dassault Systèmes, has partnered with Lambda Therapeutics to automate and consolidate data management processes for improved clinical trial efficiency.
Through the tie-up, both companies aim to safely provide advanced data for faster insights.
Go deeper with GlobalData
Lambda Therapeutics will employ Medidata’s Rave EDC, Rave RTSM, and Rave Imaging cloud-driven clinical solutions to access centralised data to address the entire clinical research process.
The intelligent workflows of Rave Imaging are capable of simplifying the collection of images and data. They can also be configured to quickly conduct edit checks and de-identification while uploading images.
After uploading, the system automates the distribution and review procedures.
See Also:
The solution’s image submission approach simplifies workflows and enhances efficiency, thereby minimising the time and expenses of image management.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataCombining Rave Imaging with EDC enables the collection of critical data to help manage clinical trials for a unified data platform that saves time, resources and costs.
Rave RTSM, which has been developed on Rave EDC, eliminates double data entry and requires reduced reconciliation that speeds up study start-up and close-out.
Lambda Therapeutics founder and managing director Bindi Chudgar said: “As Lambda Therapeutics positions itself for growth globally, we needed a data management solution that can keep up with our needs.
“Medidata’s solutions will enable us to enhance clinical trials and research timelines and strengthen our competitive advantage globally.”
Based in India, the company provides diverse clinical trial solutions such as Phases ll to lV late-phase clinical efficacy and safety patient-based studies, early-phase development, and data management, among others.
The latest partnership comes shortly after Launch Therapeutics selected Medidata’s AI Intelligent Trials solution for improved clinical trials capability.
